AplusA Research

What AplusA Research does

AplusA Research (legal name APLUSA; brand AplusA Research) is a private, France-headquartered B2B market research agency specialized in the global healthcare industry. The firm is registered in France under number 440 430 569, operates from offices in Boulogne-Billancourt (Paris region), Lyon, London, and New York, and reports a headcount of 51–100 employees. It targets primarily pharmaceutical and life sciences enterprises, with secondary buyers in Medical Affairs and Market Access/HEOR teams within those accounts. The company states 36 years of expertise in generating Real-World Evidence and claims operational reach in 75+ countries via trusted local partners.

The product platform is built around three core solutions: Custom Research (bespoke qualitative and quantitative studies, often multi-year, sometimes pharmacovigilance-bearing), Therapy Intelligence™ (a pre-built, modular syndicated study covering up to 45 countries on an annual subscription that is PV-exempt), and Real World Evidence (data-driven analytics supporting PASS, preference, consensus, and adherence studies). These are wrapped in a Product Lifecycle framework spanning Market Exploration, Value Assessment, and Brand Performance. The analytical stack layers AI/ML sub-products — AI Forecasting (regression, discriminant, random forest), Smart Segmentation (decision trees), and Clustering & Profiling (K-means, Hierarchical Cluster Analysis) — over a proprietary Patient Fitness measurement approach incorporating co-morbidities, age, performance status, quality of life, and functional capacity. Therapeutic coverage spans Solid Tumors, Hematology, Immunology, Dermocosmetics, and Emerging Therapies.

APLUSA's commercial model is consultative enterprise field sales anchored by a Global VP Commercial, a VP Commercial France, a Strategic Partnership Director, and vertical VPs (e.g., Derma-Aesthetic); distribution is direct, with engagement initiated through expert scoping sessions scheduled via HubSpot. Pricing is quote-based and non-public, combining multi-year project pricing (Custom Research and RWE) with an annual shared-cost subscription (Therapy Intelligence™) and data-based pricing for RWE. Revenue, funding history, and ownership structure are not publicly disclosed; no parent company or external investor is identified, implying founder/management-led ownership. Quality credentials include an ISO 2025 certification and a May 2026 EcoVadis Bronze Medal.

Name

AplusA Research

Legal name

APLUSA

Website

https://aplusaresearch.com

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

51–100 employees

Short description

AplusA Research is a France-headquartered B2B healthcare market research agency serving pharmaceutical and life sciences clients globally via Custom Research, syndicated Therapy Intelligence™, and Real World Evidence solutions supported by AI/ML analytics across oncology, hematology, immunology, dermocosmetics, and emerging therapies.

Ownership category

akta.pro rank

Product category

Healthcare Market Research

NAICS

Marketing Research and Public Opinion Polling (54191)

SIC

Services-Advertising (7310)

akta.pro primary industry

Market Research & Consumer Insights (BPAHALAA)

akta.pro secondary industry

B2B / Industrial Market Research (MPAAALAA)

Keywords

• Healthcare market research
• Real world evidence
• Pharmaceutical market intelligence
• Patient journey analytics
• Syndicated therapy studies

Headquarters

HQ city

Lyon

HQ country

France

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Custom Research Services: Fully tailored bespoke research studies designed around unique client business objectives. Combines qualitative and quantitative approaches with flexible pricing (Custom pricing model). May require pharmacovigilance compliance.
2. Therapy Intelligence™: Pre-built syndicated market intelligence solution with modular flexibility. Shared cost model across multiple clients, available in up to 45 countries. PV-exempt, enabling fast access to data without pharmacovigilance obligations.
3. Real World Evidence: Custom analytics based on existing real-world data. Supports non-interventional research including PASS, preference, consensus and adherence studies. Data-based pricing structure.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

AplusA Research is a B2B healthcare market research agency that delivers custom research, syndicated Therapy Intelligence™ modules, and Real-World Evidence analytics to pharmaceutical, biotech, and life sciences clients globally. Its offerings span the full product lifecycle from market exploration through brand performance tracking, leveraging proprietary AI/ML methods such as forecasting, smart segmentation, and clustering. Coverage extends across 75+ countries with a multicultural team of 25+ nationalities.

Product overview

AplusA Research offers a unified healthcare market research platform comprising three core solutions: Custom Research (fully tailored bespoke studies with global reach across 75+ countries), Therapy Intelligence™ (pre-built syndicated insights available in up to 45 countries), and Real World Evidence (patient-centered measurement combining psychosocial science with GPPs). These integrate within a Product Lifecycle framework spanning Market Exploration (early opportunity assessment), Value Assessment (pre-launch strategy), and Brand Performance (post-launch tracking). The offering includes AI-powered analytical tools (AI Forecasting, Smart Segmentation, Clustering & Profiling) applied across five therapeutic areas: Solid Tumors, Hematology, Immunology, Dermocosmetics, and Emerging Therapies.

Differentiator

Problem solved

Functional benefit

Brands

• Therapy Intelligence™: Pre-built syndicated study solution delivering robust multi-country market intelligence data for pharmaceutical companies
• Real World Evidence (RWE)
• Fieldshop

Products and services

• Custom Research Fully tailored bespoke research studies designed around unique business objectives, combining qualitative and quantitative approaches with global reach across 75+ countries and a multicultural team of 25+ nationalities. Targets pharmaceutical and life sciences enterprises needing evidence-based answers to specific strategic questions.
• Therapy Intelligence™ Pre-built syndicated market intelligence solution providing robust multi-country data with fast access, available in up to 45 countries with a flexible modular structure. Shared cost model across multiple clients and PV-exempt, enabling rapid benchmarking for pharmaceutical companies.
• Real World Evidence Real-world data collection and analytics service combining psychosocial science and Good Pharmacoepidemiology Practices (GEPs). Captures insights from physicians, caregivers, and patients through patient chart reviews, longitudinal surveys, and tailored PROMs/PREMs to support non-interventional research including PASS, preference, consensus and adherence studies.
• Market Exploration Early-stage market research offering for pipeline assets that clarifies demand, patient flow, and opportunity size before major investment decisions. Includes market understanding, patient funnel mapping, and opportunity sizing for pharmaceutical clients.
• Value Assessment Pre-launch research studies that quantify true demand and segment physicians and patients to sharpen launch strategy and adoption planning. Includes demand studies, physician segmentation, and patient profiling for pharma and biotech clients.
• Brand Performance In-line brand tracking service that monitors awareness, uptake, messaging impact, and patient experience for post-launch growth optimization. Includes awareness/trial/usage studies, product uptake, sales force effectiveness, and recall testing for pharmaceutical brands.

Quantifiable outcome

• Patient fitness metrics tracked: 63% co-morbidities, 47% age, 57% performance status, 82% quality of life, 73% functional capacity

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• IQVIA: Global leader in life sciences analytics, RWE and market research services; directly comparable to APLUSA on RWE and pharma market intelligence, but operates at vastly larger scale as a broad incumbent.
• Clarivate (DRG / Decision Resources Group): Provider of subscription-based intelligence, market research and RWE for life sciences, including Decision Resources Group; directly comparable in syndicated insights and RWE offerings at much larger scale.
• Ipsos: Large multi-industry market research firm with a dedicated healthcare division; comparable on healthcare market research methodologies, syndicated products and global fieldwork reach.
• Kantar: Global market research powerhouse with healthcare specialty; comparable on syndicated and custom healthcare research across multiple geographies.
• Informa Pharma Intelligence (Citeline): Pharma intelligence and market research provider within Informa; comparable on syndicated insights, R&D pipeline analytics and pharma market intelligence subscription products.

Direct peers

• The Research Partnership: Specialist healthcare and pharma market research firm offering syndicated and custom studies to global pharma clients; directly comparable as a focused mid-market peer in pharma market research.
• Trinity Life Sciences: Strategic advisory and market research firm focused exclusively on the life sciences industry; comparable offering across market research, competitive intelligence and RWE with tech-enabled analytics.
• BioPlan Associates: Specialist market research firm focused on biopharma and biotech manufacturing; comparable as a niche mid-market player in healthcare/biopharma market research with proprietary syndicated data.
• Compas (CMi Group): Specialist healthcare media and market research agency serving pharma clients globally; comparable as a focused healthcare market research peer targeting similar pharmaceutical buyer groups.

Emerging players

• ZoomRx: Tech-forward healthcare market research firm offering AI-driven physician and patient insights; comparable on AI/ML-powered pharma market research and syndicated HCP data products.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/APLUSARESEARCH
• Facebookfacebook.com/549965248353386
• LinkedInlinkedin.com/company/aplusa-research

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AplusA Research